Johann Matthias Graf von der Schulenburg : Citation Profile


Are you Johann Matthias Graf von der Schulenburg?

Leibniz Universität Hannover

5

H index

2

i10 index

80

Citations

RESEARCH PRODUCTION:

35

Articles

3

Papers

EDITOR:

1

Books edited

1

Series edited

RESEARCH ACTIVITY:

   32 years (1987 - 2019). See details.
   Cites by year: 2
   Journals where Johann Matthias Graf von der Schulenburg has often published
   Relations with other researchers
   Recent citing documents: 18.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pgr520
   Updated: 2020-10-17    RAS profile: 2020-03-30    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Johann Matthias Graf von der Schulenburg.

Is cited by:

Korfhage, Thorben (4)

Geyer, Johannes (4)

Brouwer, Werner (3)

Devlin, Nancy (3)

Baji, Petra (3)

Shah, Koonal (3)

Konrad, Kai (3)

TREICH, Nicolas (2)

Bertsch, Valentin (2)

Breyer, Friedrich (2)

Péntek, Márta (2)

Cites to:

Shah, Koonal (4)

Michel-Kerjan, Erwann (3)

Devlin, Nancy (3)

Feng, Yan (3)

Zhang, Yuhao (1)

Sculpher, Mark (1)

Tsuchiya, Aki (1)

McCabe, Christopher (1)

Herr, Annika (1)

Vining, Aidan (1)

Claxton, Karl (1)

Main data


Where Johann Matthias Graf von der Schulenburg has published?


Journals with more than one article published# docs
The European Journal of Health Economics10
Health Economics Review10
The Geneva Papers on Risk and Insurance - Issues and Practice4
The Geneva Risk and Insurance Review3
Health Policy2

Recent works citing Johann Matthias Graf von der Schulenburg (2020 and 2019)


YearTitle of citing document
2019Pharmaceutical Prices: The Impact of the Launch Strategy - An Analysis of German Data. (2019). Wichardt, Philipp Christoph ; Lamping, Christian ; Bohler, Yvonne-Beatrice. In: CESifo Working Paper Series. RePEc:ces:ceswps:_7879.

Full description at Econpapers || Download paper

2019Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?. (2019). Trapero-Bertran, M ; Aranda-Reneo, I ; Ramos-Goi, J M ; Lopez-Bastida, J ; Martin, Rodriguez B ; Kanavos, P. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:152-158.

Full description at Econpapers || Download paper

2020Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland. (2020). Shah, Koonal ; Devlin, Nancy ; Ramos, Juan Manuel ; Kelleher, Dan ; Barry, Luke ; Hobbins, Anna P ; Oneill, Ciaran. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:6:p:639-646.

Full description at Econpapers || Download paper

2020Prevention efforts, insurance demand and price incentives under coherent risk measures. (2020). Kazi-Tani, Nabil ; Santibaez, Nicolas Hernandez ; Bensalem, Sarah. In: Insurance: Mathematics and Economics. RePEc:eee:insuma:v:93:y:2020:i:c:p:369-386.

Full description at Econpapers || Download paper

2020A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’. (2020). Devlin, Nancy ; Ombler, Franz ; Hansen, Paul ; Sullivan, Trudy ; Derrett, Sarah. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307026.

Full description at Econpapers || Download paper

2020Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L. (2020). O'Neill, Stephen ; Hobbins, Anna ; Barry, Luke ; Kelleher, Dan ; Doherty, Edel. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953620300204.

Full description at Econpapers || Download paper

2019From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue. (2019). Zanda, Stefania ; Lettieri, Mattia ; Caputo, Francesco ; Barile, Sergio ; Saviano, Marialuisa. In: Sustainability. RePEc:gam:jsusta:v:11:y:2019:i:5:p:1289-:d:210054.

Full description at Econpapers || Download paper

2019The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys. (2019). Brouwer, Werner ; Baji, Petra ; Pentek, Marta ; Gulacsi, Laszlo ; Zrubka, Zsombor ; Prevolnik-Rupel, Valentina ; Golicki, Dominik. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01058-x.

Full description at Econpapers || Download paper

2019Cost-of-illness studies in nine Central and Eastern European countries. (2019). Baji, Petra ; Brodszky, Valentin ; Gulacsi, Laszlo ; Hren, Rok ; Niewada, Maciej ; Simon, Judit ; Mayer, Susanne ; Tachkov, Konstantin ; Rotar, Alexandru ; Pentek, Marta ; Rencz, Fanni ; Beretzky, Zsuzsanna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01066-x.

Full description at Econpapers || Download paper

2019Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set. (2019). Grochtdreis, Thomas ; Konnopka, Alexander ; Konig, Hans-Helmut ; Dams, Judith. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:6:d:10.1007_s10198-019-01054-1.

Full description at Econpapers || Download paper

2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values. (2020). Devlin, Nancy ; Kreimeier, Simone ; Ramos-Goi, Juan Manuel ; Shah, Koonal K. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01205-9.

Full description at Econpapers || Download paper

2020Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Gerdtham, Ulf-G. ; Leidl, Reiner ; Ulf-G. Gerdtham, ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7.

Full description at Econpapers || Download paper

2019Is the Validity of Cost Utility Analysis Improved When Utility is Measured by an Instrument with ‘Home-Country’ Weights? Evidence from Six Western Countries. (2019). Richardson, Jeff ; Khan, Munir A. In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. RePEc:spr:soinre:v:145:y:2019:i:1:d:10.1007_s11205-019-02094-z.

Full description at Econpapers || Download paper

2020Mutual or stock insurance: Solidarity in the face of insolvency.. (2020). Zaparova, Debora. In: Working Papers of BETA. RePEc:ulp:sbbeta:2020-06.

Full description at Econpapers || Download paper

2019Pharmaceutical prices: The impact of the launch strategy. An analysis of German data. (2019). Wichardt, Philipp C ; Lamping, Christian ; Bohler, Yvonne-Beatrice. In: Kiel Working Papers. RePEc:zbw:ifwkwp:2141.

Full description at Econpapers || Download paper

2019Schätzung kleinräumiger Krankheitshäufigkeiten für die deutsche Bevölkerung anhand von Routinedaten am Beispiel von Typ-2-Diabetes. (2019). Schroder, Helmut ; Munnich, Ralf ; Krause, Joscha ; Burgard, Jan Pablo ; Bruckner, Gabriela ; Breitkreuz, Jan ; Schussel, Katrin. In: AStA Wirtschafts- und Sozialstatistisches Archiv. RePEc:spr:astaws:v:13:y:2019:i:1:d:10.1007_s11943-019-00241-z.

Full description at Econpapers || Download paper

2019EQ-5D-5L Valuation for the Malaysian Population. (2019). Aryani, Faridah ; Rand-Hendriksen, Kim ; Luo, Nan ; Lim, Ching Jou ; Thakumar, Annushiah Vasan ; Shafie, Asrul Akmal . In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:5:d:10.1007_s40273-018-0758-7.

Full description at Econpapers || Download paper

Johann Matthias Graf von der Schulenburg is editor of


Journal
Health Economics Review

Johann Matthias Graf von der Schulenburg has edited the books:


YearTitleTypeCited

Works by Johann Matthias Graf von der Schulenburg:


YearTitleTypeCited
1987Voting on Social Security: The Family as Decision‐Making Unit In: Kyklos.
[Full Text][Citation analysis]
article7
2014Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürf In: Schmollers Jahrbuch : Journal of Applied Social Science Studies / Zeitschrift für Wirtschafts- und Sozialwissenschaften.
[Full Text][Citation analysis]
article0
2012Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study In: Health Policy.
[Full Text][Citation analysis]
article3
2002Diffusion of innovations: treatment of Alzheimers disease in Germany In: Health Policy.
[Full Text][Citation analysis]
article0
2015Cost of poor adherence to anti-hypertensive therapy in five European countries In: Post-Print.
[Citation analysis]
paper2
2014Grundlagen und Methoden von GKV-Routinedatenstudien In: Hannover Economic Papers (HEP).
[Full Text][Citation analysis]
paper3
2007Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany? In: Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik).
[Full Text][Citation analysis]
article0
1991Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered In: The Geneva Risk and Insurance Review.
[Full Text][Citation analysis]
article12
2009Reinsurance Brokers and Advice Quality: Is There a Need for Regulation? In: The Geneva Risk and Insurance Review.
[Full Text][Citation analysis]
article2
2012Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany In: The Geneva Risk and Insurance Review.
[Full Text][Citation analysis]
article1
2010On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article3
2010Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need* In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article6
2017An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article0
2019Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article0
2013Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe In: CEIS Research Paper.
[Full Text][Citation analysis]
paper0
2016Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2010Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2010EJHE has an official impact factor of 1.337 In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2011Letter from the editors In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2015Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2016Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article4
2002Commentary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2005Validating the EQ-5D with time trade off for the German population In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article15
2005German health care system in transition In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2005Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2007Editor’s note In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2011Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers In: Health Economics Review.
[Full Text][Citation analysis]
article2
2011Greetings from the Editors In: Health Economics Review.
[Full Text][Citation analysis]
article0
2011Promoting vaccinations - an analysis of measures taken by German statutory health insurers In: Health Economics Review.
[Full Text][Citation analysis]
article0
2012Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany In: Health Economics Review.
[Full Text][Citation analysis]
article0
2013Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system In: Health Economics Review.
[Full Text][Citation analysis]
article0
2015Regional differences in health care of patients with inflammatory bowel disease in Germany In: Health Economics Review.
[Full Text][Citation analysis]
article0
2015Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis - In: Health Economics Review.
[Full Text][Citation analysis]
article0
2016Benefit assessment in Germany: implications for price discounts In: Health Economics Review.
[Full Text][Citation analysis]
article2
2016Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks In: Health Economics Review.
[Full Text][Citation analysis]
article1
2018“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations In: Health Economics Review.
[Full Text][Citation analysis]
article0
2018German Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]
article8
1993Bonus options in health insurance by Peter Zweifel. Awer Academic Publishers, Dordrecht, 1992. No. of ges: xii + 141. ISBN 0‐7923‐1722‐X In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2020. Contact: CitEc Team